← All diseases
Cancer
Chronic lymphocytic leukemia
Would you like to receive a message when there is new research on Chronic Lymphocytic Leukemia? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a sentence above each publication explains what was studied — and you'll receive a notification as soon as there is new research about Chronic lymphocytic leukemia. View what Premium costs.
Publications and studies (1769)
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Central Nervous System Involvement by Small Lymphocytic Lymphoma after a Myxoma-Related Embolic Event. (2019/11/15) ♡
- A Three-Gene Expression Signature Identifies a Cluster of Patients with Short Survival in Chronic Lymphocytic Leukemia. (2019/11/07) ♡
- Protein Paucimannosylation Is an Enriched N-Glycosylation Signature of Human Cancers. (2019/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Angioedema as a systemic disease. (2019/11/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Antecedent chronic lymphocytic leukemia may be associated with more aggressive mycosis fungoides. (2019/11/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pyoderma gangrenosum developing after chest tube placement in a patient with chronic lymphocytic leukemia. (2019/11/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case of refractory chronic lymphocytic leukaemia with an unusual course. (2019/11/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Natural Killer Cell Hypo-responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating Signaling. (2019/10/30) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Characteristics of chronic lymphocytic leukemia in Togo]. (2019/10/11) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Mantle cell lymphoma diagnosed from radical prostatectomy for prostate adenocarcinoma: a case report. (2019/10/01) ♡
- Cancer incidence and congenital anomalies evaluation in the contaminated sites of Sesto San Giovanni - the SENTIERI Project. (2019/10/01) ♡
- Sortilin as a Novel Diagnostic and Therapeutic Biomarker in Chronic Lymphocytic Leukemia. (2019/10/01) ♡
- A Comparison of Cytotoxic Effects of Mangifera Indica L. and Juglans RegiaAqueous Extract on Human Chronic Lymphocytic Leukemia. (2019/10/01) ♡
- Whipple's Disease as the First Manifestation of Chronic Lymphocytic Leukaemia. (2019/09/25) ♡
- STAT3 promotes chronic lymphocytic leukemia progression through upregulating SMYD3 expression. (2019/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Minimal Residual Disease Assessment in CLL: Ready for Use in Clinical Routine? (2019/08/09) ♡
- Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia. (2019/08/01) ♡
- Hepatitis B virus screening in patients with non-Hodgkin lymphoma in clinical practice in Poland - a report of the Polish Lymphoma Research Group. (2019/07/18) ♡
- The efficacy analysis of allogeneic hematopoietic stem cell transplantation in 48 leukemia patients with central nervous system leukemia. (2019/07/14) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis. (2019/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. CD84 cell surface signaling molecule: An emerging biomarker and target for cancer and autoimmune disorders. (2019/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. SLAMF1/CD150 in hematologic malignancies: Silent marker or active player? (2019/07/01) ♡
- Highlights in Chronic Lymphocytic Leukemia From the 2019 American Society of Clinical Oncology Annual Meeting. (2019/07/01) ♡
- Highlights in Chronic Lymphocytic Leukemia From the 2019 American Society of Clinical Oncology Annual Meeting: Commentary. (2019/07/01) ♡
- PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia. (2019/06/01) ♡
- High cortactin expression in B-cell acute lymphoblastic leukemia is associated with increased transendothelial migration and bone marrow relapse. (2019/06/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Durable Response to Venetoclax Monotherapy in Richter's Syndrome: A Case Report and Review of Literature. (2019/06/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Herpes Simplex Necrotic Lymphadenitis Masquerading as Richter's Transformation in Treatment-Naive Patients With Chronic Lymphocytic Leukemia. (2019/06/01) ♡
- CLL2-BIG: sequential treatment with bendamustine, ibrutinib and obinutuzumab (GA101) in chronic lymphocytic leukemia. (2019/05/01) ♡
- Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis. (2019/05/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Kidney transplantation for treatment of end-stage kidney disease after haematopoietic stem cell transplantation: case series and literature review. (2019/04/01) ♡
- Reduced Dose Ibrutinib Due to Financial Toxicity in CLL. (2019/04/01) ♡
- Prognostic Significance of Serum BAFF, APRIL, TACI and BCMA Levels in Chronic Lymphocytic Leukemia. (2019/04/01) ♡
- Leukemia Cutis: A Rare Initial Presentation of Chronic Lymphocytic Leukemia. (2019/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma. (2019/03/12) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia. (2019/03/07) ♡
- MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL. (2019/03/01) ♡
- Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study. (2019/03/01) ♡
- Kinetics of T-cell subset reconstitution following treatment with bendamustine and rituximab for low-grade lymphoproliferative disease: a population-based analysis. (2019/03/01) ♡
- Loss of NFAT2 expression results in the acceleration of clonal evolution in chronic lymphocytic leukemia. (2019/03/01) ♡
- AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival. (2019/03/01) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018. (2019/03/01) ♡
- Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells. (2019/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. CD8 Antigen Expression in Chronic Lymphocytic Leukemia: Does it Have any Relevant Meaning? (2019/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Peripheral nervous system involvement in lymphomas. (2019/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Efficacy of Ibrutinib-Based Regimen in Chronic Lymphocytic Leukemia: A Systematic Review. (2019/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Durable remissions with obinutuzumab-based chemoimmunotherapy: long-term follow-up of the phase 1b GALTON trial in CLL. (2019/02/28) ♡
- Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation. (2019/02/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management. (2019/02/08) ♡
- Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis. (2019/02/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.